Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
"... and the sp won't move ( unless the RNS comes after a significant extra release of data from UNIVERSAL, which shows they really do know how to identify the patients )"
Yes. Good UNIVERSAL data is critical to success.
I suspect they will wait for ALL the UNIVERSAL data to come in before starting the P2s because it is the last roll of the dice and, IIRC, the current data was uncertain.
Aimtrader - All this is going to be deleted tomorrow and your account will probably be deleved for ramping as well.
If they don't get the right bio-markers from the UNIVERSAL study and elsewhere, then I suspect they will try to kick the can down the road again. They have to get it right this time and accurate bio-markers to identify the most suitable patients are essential for the P2s to succeed.
Andrewcapp - You know the man is behind the screen name of org? What was revealed in the legal case?
So there are four main characters posting here:
the war hero
poor little orphan boy
the cretin over on azn ... and ...
mrcosts
This is all about waiting for the P2 results now.
I suspect there are arrangements in place with a BP (J&J) for a JV *if* the results are statistically significant and suggest the target market is large enough.